Literature DB >> 31942553

Left ventricular mass index and subendocardial myocardial function in children with chronic kidney disease, a transmural strain and three-dimensional echocardiographic study.

Amira Esmat El Tantawy1, Fatina Fadel2, Safaa M Abdelrahman2, Marwa Nabhan2, Reem Ibrahim1, Aya M Fattouh1, Shaimaa El Sayed2, Khaled Mohamed ElKhashab3, Peter Afdal4, Antoine Fakhry AbdelMassih1.   

Abstract

Introduction: Left ventricular hypertrophy (LVH) is the commonest myocardial response to chronic kidney disease (CKD); this response has been regarded detrimental as it impairs the blood flow to the deepest layers of the myocardium causing progressive myocardial dysfunction. The aim of these series is to assess the determinants of LVH in CKD patients and its impact on subendocardial function in such patients.
Methods: This study has been conducted on 40 CKD patients (Group 1) and 40 age-matched controls, both groups were assessed by transmural echocardiography to determine the subepicardial and subendocardial global longitudinal strain (GLS) as an expression of the systolic function of each of those layers. LVH was assessed by calculation of left ventricle mass index (LVMI). Both groups underwent ambulatory blood pressure monitoring. Group 1 was assessed as regards lipid profile and insulin resistance by homeostasis model assessment of insulin resistance (HOMA-IR).
Results: HOMA-IR proved to be a more important determinant of LV hypertrophy than SBP and DBP with a P of 0.01. Moreover subendocardial GLS was negatively correlated with LVMI with r = 0.69 and P < 0.01 denoting the negative effect. LVH plays on subendocardial function probably by impairing myocardial perfusion.
Conclusion: This study points toward the importance of insulin resistance in aggravation of myocardial remodeling in CKD patients; more studies are warranted to examine the role of insulin Sensitizers in reversing such remodeling and restoring subendocardial function in such important systemic disorder.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; insulin resistance; left ventricular hypertrophy; subendocardial dysfunction

Year:  2019        PMID: 31942553      PMCID: PMC6946150          DOI: 10.1097/XCE.0000000000000186

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  19 in total

Review 1.  ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).

Authors:  Melvin D Cheitlin; William F Armstrong; Gerard P Aurigemma; George A Beller; Fredrick Z Bierman; Jack L Davis; Pamela S Douglas; David P Faxon; Linda D Gillam; Thomas R Kimball; William G Kussmaul; Alan S Pearlman; John T Philbrick; Harry Rakowski; Daniel M Thys; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  J Am Soc Echocardiogr       Date:  2003-10       Impact factor: 5.251

Review 2.  Obesity in CKD--what should nephrologists know?

Authors:  Peter Stenvinkel; Carmine Zoccali; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

3.  Left ventricular diastolic dysfunction without left ventricular hypertrophy in obese children and adolescents: a Tissue Doppler Imaging and Cardiac Troponin I Study.

Authors:  Sonia A El Saiedi; Marwa F Mira; Sahar A Sharaf; Maysoun M Al Musaddar; Rania M H El Kaffas; Antoine F AbdelMassih; Ihab H Y Barsoum
Journal:  Cardiol Young       Date:  2017-08-07       Impact factor: 1.093

4.  Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men.

Authors:  J Sundström; L Lind; N Nyström; B Zethelius; B Andrén; C N Hales; H O Lithell
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

5.  Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension.

Authors:  K Watanabe; M Sekiya; T Tsuruoka; J Funada; H Kameoka
Journal:  J Hypertens       Date:  1999-08       Impact factor: 4.844

Review 6.  Metabolic consequences of hyperglycemia and insulin resistance.

Authors:  Paul S Jellinger
Journal:  Clin Cornerstone       Date:  2007

Review 7.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

Review 8.  Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.

Authors:  Luca Di Lullo; Antonio Gorini; Domenico Russo; Alberto Santoboni; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-07-15       Impact factor: 2.041

Review 9.  Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.

Authors:  Ihab M Wahba; Robert H Mak
Journal:  Clin J Am Soc Nephrol       Date:  2007-03-14       Impact factor: 8.237

10.  Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

Authors:  Richard E Katholi; Daniel M Couri
Journal:  Int J Hypertens       Date:  2011-06-30       Impact factor: 2.420

View more
  1 in total

1.  Revisiting the pathogenic role of insulin resistance in Duchenne muscular dystrophy cardiomyopathy subphenotypes.

Authors:  Antoine Fakhry AbdelMassih; Reem Esmail; Hanan Zekri; Ahmed Kharabish; Khaled ElKhashab; Rahma Menshawey; Habiba-Allah Ismail; Peter Afdal; Erini Farid; Omneya Affifi
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.